Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2008
03/11/2008US7341731 HIV-2 antigen compositions
03/11/2008US7341730 Inhibitors of angiogenesis and tumor growth
03/11/2008US7341728 Internalisation of virus into cells
03/11/2008US7341724 Apoptosis of rectum and prostate gland cancer
03/11/2008US7341723 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide
03/11/2008US7341721 Agent that interacts with MHC beta2-microglobulin HLA class 1 molecules located on the tumor cell surface
03/11/2008US7341720 Targeting of glycoprotein therapeutics
03/11/2008US7341718 Neuronal gene transfer of adenovirus and herpes virus vectors
03/11/2008US7341717 Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor
03/11/2008US7341710 Method of identifying molecules that home to a selected organ in vivo
03/11/2008CA2444561C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
03/11/2008CA2408548C Method for the preparation of polymeric micelle via phase separation of block copolymer
03/11/2008CA2391647C Biomolecular complex formed between hyaluronic acid and a biomolecule
03/11/2008CA2317107C Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
03/11/2008CA2300358C Novel phytase
03/11/2008CA2203372C Human scf, a splice variant thereof, its pharmaceutical use
03/11/2008CA2179857C Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury
03/11/2008CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
03/11/2008CA2108135C Method and composition for the treatment of herpes related disorders
03/08/2008WO2008039173A2 Methods and compositions for inhibiting cell death or enhancing cell proliferation
03/08/2008CA2622504A1 Methods and compositions for inhibiting cell death or enhancing cel proliferation
03/06/2008WO2008028065A2 Sirt activation in managing heart failure
03/06/2008WO2008028002A1 Increasing nadph-dependent products
03/06/2008WO2008027904A2 Dry wound dressing and drug delivery system
03/06/2008WO2008027854A2 Pharmaceutical compositions comprising hgh for oral delivery
03/06/2008WO2008027839A1 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists
03/06/2008WO2008027807A2 Control of diabetes and obesity
03/06/2008WO2008027687A2 Use of tenecteplase for treating acute ischemic stroke
03/06/2008WO2008027526A1 Methods relating to peripheral administration of nogo receptor polypeptides
03/06/2008WO2008027288A2 Treatment for craniosynostosis by growth factor delivery
03/06/2008WO2008027210A2 Biocompatible stent
03/06/2008WO2008027017A1 Modulation of neural activity and/or condition
03/06/2008WO2008027000A2 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
03/06/2008WO2008026999A2 Candidates against infection
03/06/2008WO2008026349A1 Therapeutic agent for telogen effluvium
03/06/2008WO2008026334A1 Agent for inhibiting intestinal permeation of allergen
03/06/2008WO2008026320A1 ANTI-ANGIOGENIC AGENT, DNA SYNTHESIS INHIBITOR, p44/p42 MAPK PHOSPHORYLATION ACTIVITY INHIBITOR, AND MEDICAL KIT
03/06/2008WO2008026298A1 Remedy for kidney disease
03/06/2008WO2008026224A2 Novel nanoparticles of apotransferrin / transferrin, pharmaceutical composition containing them and processes for their preparation
03/06/2008WO2008026014A1 Management of non septic patients suffering from partial thickness burns during the first 48 postburn hours by administration of activated protein c
03/06/2008WO2008025991A1 Crystal structure of the thsr receptor
03/06/2008WO2008025856A2 Modified glycoproteins
03/06/2008WO2008025830A2 Pharmaceutical and sunscreen compositions comprising caspase-14
03/06/2008WO2008025747A1 Process for the purification of fc-fusion proteins
03/06/2008WO2008025425A1 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
03/06/2008WO2008025163A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity
03/06/2008WO2008025152A1 Antibacterial agents
03/06/2008WO2008025130A1 Method for ameliorating pain by modification of nmda receptors through inhibition of src
03/06/2008WO2008025094A1 Method of treatment of photodermatoses
03/06/2008WO2008025074A1 Method for reducing incidence or rate of development of skin cancers and related conditions
03/06/2008WO2008008923A3 Compositions and methods for targeting cancer-specific transcription complexes
03/06/2008WO2008008873A3 Clc channel ligand
03/06/2008WO2008008549A3 Combination of an immunosuppressive agent and nonsteroidal anti -inflammatory drugs to treat neoplasia
03/06/2008WO2008006458A3 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them
03/06/2008WO2008006070A3 Compounds and combinations thereof for inhibiting beta-amyloid production and methods of use thereof
03/06/2008WO2008005985A3 Insulin-like growth factor-1 receptor antagonists
03/06/2008WO2007143119A3 Method of preventing progression of hypertension-induced heart failure with pkc peptides
03/06/2008WO2007128817A3 Insulin derivative
03/06/2008WO2007126364A3 Use of antisecretory factors for treating intraocular hypertension
03/06/2008WO2007117467B1 Use of tm-601 for the diagnosis and treatment of tumors
03/06/2008WO2007109609A3 Method for inhibiting angiogenesis
03/06/2008WO2007106986A8 Dosing regimes for lh or hcg and epo for treatment of neurological disorders
03/06/2008WO2007106435A3 Cleavable vaccines compositions and methods of making and using the same
03/06/2008WO2007100607A3 Immunogenic peptides and methods of use
03/06/2008WO2007098361A3 Laminate structure suitable for furniture exteriors
03/06/2008WO2007093373A3 Branched multimeric peptides for tumor diagnosis and therapy
03/06/2008WO2007089688A3 Na/k-atpase ligand
03/06/2008WO2007087154A3 Methods for enhancing therapeutic effects of a neurotoxin
03/06/2008WO2007067611A3 Methods of treating cardiac reperfusion disease
03/06/2008WO2007053800A3 Charge-modified lysozyme antimicrobial compositions, surfactants, and methods for infections and cystic fibrosis
03/06/2008WO2005032482A8 Treatment of demyelinating autoimmune disease with modified ordered peptides
03/06/2008WO2001040439A3 CLONING AND EXPRESSION OF A DNA SEQUENCE ENCODING A 41 kDa CRYPTOSPORIDIUM PARVUM OOCYST WALL PROTEIN
03/06/2008US20080058762 Induction And Maintenance Of Tolerance To Composite Tissue Allografts
03/06/2008US20080058636 Methods of myocardial imaging
03/06/2008US20080058546 Methods for Synthesis of Acyloxyalkyl Derivatives of GABA Analogs
03/06/2008US20080058505 Modified parathyroid hormone/peptides for use in prevention and treatment of bone disorders
03/06/2008US20080058433 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
03/06/2008US20080058360 Soluble CD40L (CD 154) as a prognostic marker of atherosclerotic diseases
03/06/2008US20080058336 Secretase inhibitor
03/06/2008US20080058306 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitors(s) and treatments for vascular indications
03/06/2008US20080058303 Antiinflammatory agents
03/06/2008US20080058277 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
03/06/2008US20080058272 Fibroblast activated protein; antitumor agents, anticancer agents
03/06/2008US20080058271 Dtection of autoantigen; diagnosis, therapy of autoimmune disease
03/06/2008US20080058270 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
03/06/2008US20080058269 Insulin Releasing Peptides
03/06/2008US20080058268 Methods and Agents for the Treatment of Cancer
03/06/2008US20080058267 Combinatorial therapy; genetic engineered protein; therapy for autoimmune diaeses; anticancer agents
03/06/2008US20080058266 Pharmaceutical Compositions Comprising Factor VII Polypeptides and Factor XI Polypeptides
03/06/2008US20080058265 Methods and compositions for activated protein c with reduced anti-coagulant properties
03/06/2008US20080058264 Mixture of leucine and threonine
03/06/2008US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators
03/06/2008US20080058262 rPA optimization
03/06/2008US20080058261 Protease susceptibility II
03/06/2008US20080058260 Reversible inhibition of pyramidal gap junction activity
03/06/2008US20080058259 Improve metabolism of humans; administering mixture of insulin-like growth factor and growth hormone; particlar pediatic humans
03/06/2008US20080058258 Growth Factor
03/06/2008US20080058257 Semaphorin protein; gene expression on surface dendritic cells
03/06/2008US20080058256 Metalloproteinase polypeptide; in vivo lysis of blood clots; genetic engineering; gene expression
03/06/2008US20080058255 Human coagulation polypeptides, polynucleotides
1 ... 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 ... 3163